Selected research
Market Analysis & Forecast
Global Valbenazine Market Analysis and Forecast 2026-2032
Market perspective
The global Valbenazine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Valbenazine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Valbenazine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Valbenazine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Valbenazine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Valbenazine include Vcare Pharmatech, Toronto Research Chemicals, TargetMol, Neurocrine Biosciences, Clearsynth, BOC Sciences and Adooq Bioscience, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Valbenazine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Valbenazine, also provides the sales of main regions and countries. Of the upcoming market potential for Valbenazine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valbenazine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valbenazine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valbenazine sales, projected growth trends, production technology, application and end-user industry.
Valbenazine Segment by Company
Vcare Pharmatech
Toronto Research Chemicals
TargetMol
Neurocrine Biosciences
Clearsynth
BOC Sciences
Adooq Bioscience
Valbenazine Segment by Type
40mg Capsule
60mg Capsule
80mg Capsule
Valbenazine Segment by Application
Tardive Dyskinesia
Tourette Syndrome
Valbenazine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Valbenazine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valbenazine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Capsule
- 60mg Capsule
- 80mg Capsule
Applications
- Tardive Dyskinesia
- Tourette Syndrome
Companies covered
- Vcare Pharmatech
- Toronto Research Chemicals
- TargetMol
- Neurocrine Biosciences
- Clearsynth
- BOC Sciences
- Adooq Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Valbenazine Market by Type
- 1.2.1 Global Valbenazine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 40mg Capsule
- 1.2.3 60mg Capsule
- 1.2.4 80mg Capsule
- 1.3 Valbenazine Market by Application
- 1.3.1 Global Valbenazine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Tardive Dyskinesia
- 1.3.3 Tourette Syndrome
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Valbenazine Market Dynamics
- 2.1 Valbenazine Industry Trends
- 2.2 Valbenazine Industry Drivers
- 2.3 Valbenazine Industry Opportunities and Challenges
- 2.4 Valbenazine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Valbenazine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Valbenazine Revenue by Region
- 3.2.1 Global Valbenazine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Valbenazine Revenue by Region (2021-2026)
- 3.2.3 Global Valbenazine Revenue by Region (2027-2032)
- 3.2.4 Global Valbenazine Revenue Market Share by Region (2021-2032)
- 3.3 Global Valbenazine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Valbenazine Sales by Region
- 3.4.1 Global Valbenazine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Valbenazine Sales by Region (2021-2026)
- 3.4.3 Global Valbenazine Sales by Region (2027-2032)
- 3.4.4 Global Valbenazine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Valbenazine Revenue by Manufacturers
- 4.1.1 Global Valbenazine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Valbenazine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Valbenazine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Valbenazine Sales by Manufacturers
- 4.2.1 Global Valbenazine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Valbenazine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Valbenazine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Valbenazine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Valbenazine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Valbenazine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Valbenazine Manufacturers, Product Type & Application
- 4.7 Global Valbenazine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Valbenazine Market CR5 and HHI
- 4.8.2 2025 Valbenazine Tier 1, Tier 2, and Tier 3
5 Valbenazine Market by Type
- 5.1 Global Valbenazine Revenue by Type
- 5.1.1 Global Valbenazine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Valbenazine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Valbenazine Revenue Market Share by Type (2021-2032)
- 5.2 Global Valbenazine Sales by Type
- 5.2.1 Global Valbenazine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Valbenazine Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Valbenazine Sales Market Share by Type (2021-2032)
- 5.3 Global Valbenazine Price by Type
6 Valbenazine Market by Application
- 6.1 Global Valbenazine Revenue by Application
- 6.1.1 Global Valbenazine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Valbenazine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Valbenazine Revenue Market Share by Application (2021-2032)
- 6.2 Global Valbenazine Sales by Application
- 6.2.1 Global Valbenazine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Valbenazine Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Valbenazine Sales Market Share by Application (2021-2032)
- 6.3 Global Valbenazine Price by Application
7 Company Profiles
- 7.1 Vcare Pharmatech
- 7.1.1 Vcare Pharmatech Company Information
- 7.1.2 Vcare Pharmatech Business Overview
- 7.1.3 Vcare Pharmatech Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Vcare Pharmatech Valbenazine Product Portfolio
- 7.1.5 Vcare Pharmatech Recent Developments
- 7.2 Toronto Research Chemicals
- 7.2.1 Toronto Research Chemicals Company Information
- 7.2.2 Toronto Research Chemicals Business Overview
- 7.2.3 Toronto Research Chemicals Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Toronto Research Chemicals Valbenazine Product Portfolio
- 7.2.5 Toronto Research Chemicals Recent Developments
- 7.3 TargetMol
- 7.3.1 TargetMol Company Information
- 7.3.2 TargetMol Business Overview
- 7.3.3 TargetMol Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 TargetMol Valbenazine Product Portfolio
- 7.3.5 TargetMol Recent Developments
- 7.4 Neurocrine Biosciences
- 7.4.1 Neurocrine Biosciences Company Information
- 7.4.2 Neurocrine Biosciences Business Overview
- 7.4.3 Neurocrine Biosciences Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Neurocrine Biosciences Valbenazine Product Portfolio
- 7.4.5 Neurocrine Biosciences Recent Developments
- 7.5 Clearsynth
- 7.5.1 Clearsynth Company Information
- 7.5.2 Clearsynth Business Overview
- 7.5.3 Clearsynth Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Clearsynth Valbenazine Product Portfolio
- 7.5.5 Clearsynth Recent Developments
- 7.6 BOC Sciences
- 7.6.1 BOC Sciences Company Information
- 7.6.2 BOC Sciences Business Overview
- 7.6.3 BOC Sciences Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 BOC Sciences Valbenazine Product Portfolio
- 7.6.5 BOC Sciences Recent Developments
- 7.7 Adooq Bioscience
- 7.7.1 Adooq Bioscience Company Information
- 7.7.2 Adooq Bioscience Business Overview
- 7.7.3 Adooq Bioscience Valbenazine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Adooq Bioscience Valbenazine Product Portfolio
- 7.7.5 Adooq Bioscience Recent Developments
8 North America
- 8.1 North America Valbenazine Market Size by Type
- 8.1.1 North America Valbenazine Revenue by Type (2021-2032)
- 8.1.2 North America Valbenazine Sales by Type (2021-2032)
- 8.1.3 North America Valbenazine Price by Type (2021-2032)
- 8.2 North America Valbenazine Market Size by Application
- 8.2.1 North America Valbenazine Revenue by Application (2021-2032)
- 8.2.2 North America Valbenazine Sales by Application (2021-2032)
- 8.2.3 North America Valbenazine Price by Application (2021-2032)
- 8.3 North America Valbenazine Market Size by Country
- 8.3.1 North America Valbenazine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Valbenazine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Valbenazine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Valbenazine Market Size by Type
- 9.1.1 Europe Valbenazine Revenue by Type (2021-2032)
- 9.1.2 Europe Valbenazine Sales by Type (2021-2032)
- 9.1.3 Europe Valbenazine Price by Type (2021-2032)
- 9.2 Europe Valbenazine Market Size by Application
- 9.2.1 Europe Valbenazine Revenue by Application (2021-2032)
- 9.2.2 Europe Valbenazine Sales by Application (2021-2032)
- 9.2.3 Europe Valbenazine Price by Application (2021-2032)
- 9.3 Europe Valbenazine Market Size by Country
- 9.3.1 Europe Valbenazine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Valbenazine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Valbenazine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Valbenazine Market Size by Type
- 10.1.1 China Valbenazine Revenue by Type (2021-2032)
- 10.1.2 China Valbenazine Sales by Type (2021-2032)
- 10.1.3 China Valbenazine Price by Type (2021-2032)
- 10.2 China Valbenazine Market Size by Application
- 10.2.1 China Valbenazine Revenue by Application (2021-2032)
- 10.2.2 China Valbenazine Sales by Application (2021-2032)
- 10.2.3 China Valbenazine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Valbenazine Market Size by Type
- 11.1.1 Asia Valbenazine Revenue by Type (2021-2032)
- 11.1.2 Asia Valbenazine Sales by Type (2021-2032)
- 11.1.3 Asia Valbenazine Price by Type (2021-2032)
- 11.2 Asia Valbenazine Market Size by Application
- 11.2.1 Asia Valbenazine Revenue by Application (2021-2032)
- 11.2.2 Asia Valbenazine Sales by Application (2021-2032)
- 11.2.3 Asia Valbenazine Price by Application (2021-2032)
- 11.3 Asia Valbenazine Market Size by Country
- 11.3.1 Asia Valbenazine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Valbenazine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Valbenazine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Valbenazine Market Size by Type
- 12.1.1 SAMEA Valbenazine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Valbenazine Sales by Type (2021-2032)
- 12.1.3 SAMEA Valbenazine Price by Type (2021-2032)
- 12.2 SAMEA Valbenazine Market Size by Application
- 12.2.1 SAMEA Valbenazine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Valbenazine Sales by Application (2021-2032)
- 12.2.3 SAMEA Valbenazine Price by Application (2021-2032)
- 12.3 SAMEA Valbenazine Market Size by Country
- 12.3.1 SAMEA Valbenazine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Valbenazine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Valbenazine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Valbenazine Value Chain Analysis
- 13.1.1 Valbenazine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Valbenazine Production Mode & Process
- 13.2 Valbenazine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Valbenazine Distributors
- 13.2.3 Valbenazine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst